In conclusion, a novel prognostic prediction model based on three IRGs (MAP3K8, SECTM1, IGLV7-43) was developed, which effectively predicts the survival rates of ESCC patients. The gene discussed is SECTM1; the disease is esophageal squamous cell carcinoma.